Neoadjuvant endocrine therapy use in early stage breast cancer during the covid-19 pandemic


Journal article


Ko Un Park, M. Gregory, J. Bazán, M. Lustberg, Shoshana M. Rosenberg, V. Blinder, P. Sharma, L. Pusztai, Chengli Shen, A. Partridge, A. Thompson
Breast Cancer Research and Treatment, 2021

Semantic Scholar DOI PubMedCentral PubMed
Cite

Cite

APA   Click to copy
Park, K. U., Gregory, M., Bazán, J., Lustberg, M., Rosenberg, S. M., Blinder, V., … Thompson, A. (2021). Neoadjuvant endocrine therapy use in early stage breast cancer during the covid-19 pandemic. Breast Cancer Research and Treatment.


Chicago/Turabian   Click to copy
Park, Ko Un, M. Gregory, J. Bazán, M. Lustberg, Shoshana M. Rosenberg, V. Blinder, P. Sharma, et al. “Neoadjuvant Endocrine Therapy Use in Early Stage Breast Cancer during the Covid-19 Pandemic.” Breast Cancer Research and Treatment (2021).


MLA   Click to copy
Park, Ko Un, et al. “Neoadjuvant Endocrine Therapy Use in Early Stage Breast Cancer during the Covid-19 Pandemic.” Breast Cancer Research and Treatment, 2021.


BibTeX   Click to copy

@article{ko2021a,
  title = {Neoadjuvant endocrine therapy use in early stage breast cancer during the covid-19 pandemic},
  year = {2021},
  journal = {Breast Cancer Research and Treatment},
  author = {Park, Ko Un and Gregory, M. and Bazán, J. and Lustberg, M. and Rosenberg, Shoshana M. and Blinder, V. and Sharma, P. and Pusztai, L. and Shen, Chengli and Partridge, A. and Thompson, A.}
}